145 related articles for article (PubMed ID: 35147730)
1. Long-term follow-up of respiratory function in facioscapulohumeral muscular dystrophy.
Teeselink S; Vincenten SCC; Voermans NC; Groothuis JT; Doorduin J; Wijkstra PJ; Horlings CGC; van Engelen BGM; Mul K
J Neurol; 2022 Jul; 269(7):3682-3689. PubMed ID: 35147730
[TBL] [Abstract][Full Text] [Related]
2. Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy.
Moreira S; Wood L; Smith D; Marini-Bettolo C; Guglieri M; McMacken G; Bailey G; Mayhew A; Muni-Lofra R; Eglon G; Williams M; Straub V; Lochmüller H; Evangelista T
J Neurol; 2017 Jun; 264(6):1271-1280. PubMed ID: 28550484
[TBL] [Abstract][Full Text] [Related]
3. Respiratory muscle weakness in facioscapulohumeral muscular dystrophy.
Henke C; Spiesshoefer J; Kabitz HJ; Herkenrath S; Randerath W; Brix T; Görlich D; Young P; Boentert M
Muscle Nerve; 2019 Dec; 60(6):679-686. PubMed ID: 31566774
[TBL] [Abstract][Full Text] [Related]
4. Respiratory pattern in a FSHD pediatric population.
Trucco F; Pedemonte M; Fiorillo C; Tacchetti P; Brisca G; Bruno C; Minetti C
Respir Med; 2016 Oct; 119():78-80. PubMed ID: 27692152
[TBL] [Abstract][Full Text] [Related]
5. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
[TBL] [Abstract][Full Text] [Related]
6. A case of type 1 facioscapulohumeral muscular dystrophy (FSHD) with restrictive ventilatory defect and congestive heart failure.
Morimoto N; Morimoto M; Takahashi Y; Takamiya M; Nishino I; Abe K
eNeurologicalSci; 2020 Dec; 21():100284. PubMed ID: 33195829
[TBL] [Abstract][Full Text] [Related]
7. Respiratory muscle dysfunction in facioscapulohumeral muscular dystrophy.
Santos DB; Boussaid G; Stojkovic T; Orlikowski D; Letilly N; Behin A; Butel S; Lofaso F; Prigent H
Neuromuscul Disord; 2015 Aug; 25(8):632-9. PubMed ID: 26023000
[TBL] [Abstract][Full Text] [Related]
8. Preliminary investigation of cardiopulmonary function in stroke patients with stable heart failure and exertional dyspnea.
Liaw MY; Wang LY; Pong YP; Tsai YC; Huang YC; Yang TH; Lin MC
Medicine (Baltimore); 2016 Oct; 95(40):e5071. PubMed ID: 27749577
[TBL] [Abstract][Full Text] [Related]
9. Restrictive lung involvement in facioscapulohumeral muscular dystrophy.
Scully MA; Eichinger KJ; Donlin-Smith CM; Tawil R; Statland JM
Muscle Nerve; 2014 Nov; 50(5):739-43. PubMed ID: 24639337
[TBL] [Abstract][Full Text] [Related]
10. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy.
Gros M; Nunes AM; Daoudlarian D; Pini J; Martinuzzi E; Barbosa S; Ramirez M; Puma A; Villa L; Cavalli M; Grecu N; Garcia J; Siciliano G; Solé G; Juntas-Morales R; Jones PL; Jones T; Glaichenhaus N; Sacconi S
J Neuromuscul Dis; 2022; 9(1):83-93. PubMed ID: 34459413
[TBL] [Abstract][Full Text] [Related]
11. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
[TBL] [Abstract][Full Text] [Related]
12. Natural History of Facioscapulohumeral Dystrophy in Children: A 2-Year Follow-up.
Dijkstra JN; Goselink RJM; van Alfen N; de Groot IJM; Pelsma M; van der Stoep N; Theelen T; van Engelen BGM; Voermans NC; Erasmus CE
Neurology; 2021 Nov; 97(21):e2103-e2113. PubMed ID: 34675094
[TBL] [Abstract][Full Text] [Related]
13. Lung volume recruitment slows pulmonary function decline in Duchenne muscular dystrophy.
McKim DA; Katz SL; Barrowman N; Ni A; LeBlanc C
Arch Phys Med Rehabil; 2012 Jul; 93(7):1117-22. PubMed ID: 22421625
[TBL] [Abstract][Full Text] [Related]
14. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
[TBL] [Abstract][Full Text] [Related]
15. Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.
Mul K; Heatwole C; Eichinger K; Dilek N; Martens WB; Van Engelen BGM; Tawil R; Statland JM
Muscle Nerve; 2018 Aug; 58(2):213-218. PubMed ID: 29543984
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
[TBL] [Abstract][Full Text] [Related]
17. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
18. Characterization of pulmonary function in Duchenne Muscular Dystrophy.
Mayer OH; Finkel RS; Rummey C; Benton MJ; Glanzman AM; Flickinger J; Lindström BM; Meier T
Pediatr Pulmonol; 2015 May; 50(5):487-94. PubMed ID: 25755201
[TBL] [Abstract][Full Text] [Related]
19. What's in a name? The clinical features of facioscapulohumeral muscular dystrophy.
Mul K; Lassche S; Voermans NC; Padberg GW; Horlings CG; van Engelen BG
Pract Neurol; 2016 Jun; 16(3):201-7. PubMed ID: 26862222
[TBL] [Abstract][Full Text] [Related]
20. Spirometry correlates with physical activity in patients with Duchenne muscular dystrophy.
Kaslow JA; Sokolow AG; Donnelly T; Buchowski MS; Markham LW; Burnette WB; Soslow JH
Pediatr Pulmonol; 2023 Apr; 58(4):1034-1041. PubMed ID: 36571207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
